Episode 197: Acute Agitation

Episode 197: Acute Agitation

Update: 2024-06-031
Share

Description





We discuss an approach to the acutely agitated patient and review medications commonly used.


Hosts:

Jonathan Kobles, MD

Brian Gilberti, MD









Download


Leave a Comment





Tags: Agitation, psychiatry, Toxicology






Show Notes


Background/Epidemiology


Definition and Scope: Agitation encompasses behaviors from restlessness to severe altered mental states. It’s a common emergency department presentation, often linked with acute medical or psychiatric emergencies.


Significance: Patients with agitation are at high risk for morbidity and mortality, necessitating prompt and effective management to prevent harm to themselves and healthcare providers.


A Changing Paradigm in Describing Agitation


Terminology Shift: Move away from terms like ‘excited delirium’ due to their politicization and stigmatization. Focus on describing agitation by severity and underlying causes.


Agitation as a Multifactorial Process


Complex Nature: Recognize agitation as a result of various factors, including medical, psychiatric, and environmental influences.


Recognizing Agitation


Signs and Symptoms: Identify agitation early by monitoring for behaviors such as hostility, pacing, non-compliance, and verbal aggression.


Initial Evaluation


Severity Assessment: Determine the severity of agitation and prioritize reversible causes and life-threatening conditions.


Diagnostic Steps: Perform vital signs check, blood glucose levels, ECG, and a targeted medical screening exam.


Life Threats


Immediate Concerns: Identify and address immediate life threats such as hypoxia, hypoglycemia, trauma, and acute neurological emergencies.


Forming a Differential Prior to Treatment


Prioritization: Severe agitation requires immediate treatment to facilitate further evaluation and reduce risk of harm.


Physician/Staff Safety


Safety Measures: Ensure personal and team safety by maintaining a calm environment and preparing for potential violence.


Multimodal Approach


Self-check In: Physicians should mentally prepare and approach the situation calmly to ensure effective management.


Verbal De-escalation: Use techniques focused on safety, therapeutic alliance, and patient autonomy to manage agitation non-pharmacologically.


Medication Administration


Oral/Sublingual Medications: Consider oral medications for less severe cases to maintain patient autonomy and avoid invasive procedures.


IM or IV Medications: Use intramuscular or intravenous medications for rapid control in severe cases.


Specific Medication Regimens


PO Regimens:


Medications: Antipsychotics like Zyprexa (olanzapine) 5-10 mg, benzodiazepines like Ativan (lorazepam) 1-2 mg.


Benefits: Empower patients with a sense of autonomy, avoid injection-related trauma.


Pharmacokinetics:


Olanzapine: Onset in 15-45 minutes, peak effect in 1-2 hours, duration 12-24 hours.


Lorazepam: Onset in 30-60 minutes, peak effect in 2 hours, duration 6-8 hours.


IV/IM Regimens:


Medications: Droperidol, haloperidol, midazolam, ketamine.


ACEP 2023 Guidelines: Recommend droperidol with midazolam or an atypical antipsychotic for severe agitation.


Pharmacokinetics (IM):


Haloperidol: IM onset in 15, time to sedation ~25 minutes, can last for 2 hours


Droperidol: IM onset in 5-10 minutes, duration 2-4 hours but can last as long as 12 hours


Midazolam: IM onset ~15 minutes, , duration 20 minutes – 2 hours.


Lorazepam: IM onset ~15-30 minutes, , duration up to 3 hours


Ketamine: IM onset in ~5 minutes, duration 5-30 minutes.


Special Situations


Elderly/Dementia: Optimize environment, use non-pharmacologic measures, avoid benzodiazepines to reduce delirium risk.


Parkinson’s Disease: Avoid antipsychotics that can precipitate a Parkinsonian crisis.


Autism/Pediatrics: Engage caregivers, create a calming environment, avoid aggressive measures.


Alcohol Withdrawal: Utilize benzodiazepines and phenobarbital.


Re-dosing and Physical Restraints


Re-dosing: Use the lowest effective dose, consider continuous monitoring, and reassess frequently.


Physical Restraints: Employ as a last resort, ensuring close monitoring for any adverse effects.


Final Points


Clinical Leadership: Physicians should lead with clear communication, planning, and support for the team.


Continuous Learning: Regular debriefing and assessment after each incident to improve future responses.


 





Read More
Comments 
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 197: Acute Agitation

Episode 197: Acute Agitation

Core EM